Is the Latest Problem at Aurora Cannabis a Mountain or a Molehill?

Aurora Cannabis (NYSE: ACB) has been no stranger to problems lately: Its shares have plunged more than 40% in just the last three months. Aurora missed expectations with its fiscal 2019 Q4 results. Analysts have piled on with negative views, with Stifel Nicolaus downgrading the stock to a sell and cutting its one-year price target by more than 30%.

The Canadian cannabis producer sorely needs some good news to renew investors' confidence. Unfortunately, the latest news for Aurora is again bad. What is this development, and just how bad is it?

Image source: Getty Images.

Continue reading

Source Fool.com